442 related articles for article (PubMed ID: 25550693)
1. The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy.
Leung J; Suh WK
Immune Netw; 2014 Dec; 14(6):265-76. PubMed ID: 25550693
[TBL] [Abstract][Full Text] [Related]
2. [Lymphocyte coreceptors].
Olive D
Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
[TBL] [Abstract][Full Text] [Related]
3. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy.
Khan M; Arooj S; Wang H
Front Immunol; 2021; 12():651634. PubMed ID: 34531847
[TBL] [Abstract][Full Text] [Related]
4. Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies.
Pulanco MC; Madsen AT; Tanwar A; Corrigan DT; Zang X
Cell Mol Immunol; 2023 Jul; 20(7):694-713. PubMed ID: 37069229
[TBL] [Abstract][Full Text] [Related]
5. B7-H3 role in the immune landscape of cancer.
Castellanos JR; Purvis IJ; Labak CM; Guda MR; Tsung AJ; Velpula KK; Asuthkar S
Am J Clin Exp Immunol; 2017; 6(4):66-75. PubMed ID: 28695059
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.
Picarda E; Ohaegbulam KC; Zang X
Clin Cancer Res; 2016 Jul; 22(14):3425-3431. PubMed ID: 27208063
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer.
Xu Z; Shen J; Wang MH; Yi T; Yu Y; Zhu Y; Chen B; Chen J; Li L; Li M; Zuo J; Jiang H; Zhou D; Luan J; Xiao Z
Oncoimmunology; 2016 Aug; 5(8):e1207841. PubMed ID: 27622076
[TBL] [Abstract][Full Text] [Related]
8. Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.
Liu W; Zang X
Adv Exp Med Biol; 2019; 1172():63-78. PubMed ID: 31628651
[TBL] [Abstract][Full Text] [Related]
9. The B7 family revisited.
Greenwald RJ; Freeman GJ; Sharpe AH
Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
[TBL] [Abstract][Full Text] [Related]
10. T cell coinhibition and immunotherapy in human breast cancer.
Janakiram M; Abadi YM; Sparano JA; Zang X
Discov Med; 2012 Oct; 14(77):229-36. PubMed ID: 23114578
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients.
Lee H; Kim JH; Yang SY; Kong J; Oh M; Jeong DH; Chung JI; Bae KB; Shin JY; Hong KH; Choi I
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1445-52. PubMed ID: 20140740
[TBL] [Abstract][Full Text] [Related]
12. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC
Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules.
D'Arrigo P; Tufano M; Rea A; Vigorito V; Novizio N; Russo S; Romano MF; Romano S
Curr Med Chem; 2020; 27(15):2402-2448. PubMed ID: 30398102
[TBL] [Abstract][Full Text] [Related]
14. T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.
Barach YS; Lee JS; Zang X
Trends Mol Med; 2011 Jan; 17(1):47-55. PubMed ID: 20971039
[TBL] [Abstract][Full Text] [Related]
15. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
16. B7 family protein glycosylation: Promising novel targets in tumor treatment.
Xiao L; Guan X; Xiang M; Wang Q; Long Q; Yue C; Chen L; Liu J; Liao C
Front Immunol; 2022; 13():1088560. PubMed ID: 36561746
[TBL] [Abstract][Full Text] [Related]
17. Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study.
Ganesan A; Moon TC; Barakat KH
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2764-2778. PubMed ID: 30251665
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy.
Zhao B; Li H; Xia Y; Wang Y; Wang Y; Shi Y; Xing H; Qu T; Wang Y; Ma W
J Hematol Oncol; 2022 Oct; 15(1):153. PubMed ID: 36284349
[TBL] [Abstract][Full Text] [Related]
19. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
[No Abstract] [Full Text] [Related]
20. The CD28-B7 Family of Co-signaling Molecules.
Nagai S; Azuma M
Adv Exp Med Biol; 2019; 1189():25-51. PubMed ID: 31758530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]